ArticleInvestigational new drugs2015
A phase I study of the histone deacetylase (HDAC) inhibitor entinostat, in combination with sorafenib in patients with advanced solid tumors.
Nuttapong Ngamphaiboon et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this papercites it